Millennium Engineering and Integration (United States)

Institution (Company)

Homepage ROR

Also Known As

Millennium, Millennium Engineering and Integration (United States)

4.5K

Publications

1.3M

Citations

620

Authors

1.5K

Concepts

About

Millennium Engineering and Integration (United States) is a company institution in Arlington, United States known for medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	58	521	40.8K
2	Health Sciences	48	467	191.8K
3	Business	18	38	3K
4	Education	15	25	2.2K
5	Arts	1	1	368

Millennium Engineering and Integration (United States)

4.5K

Publications

1.3M

Citations

Page 1

	Year	Citations
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance Haiyan Xu, Glenn T. Barnes, Qing Yang, Journal of Clinical Investigation Metabolic DisorderImmunologyInsulin SignalingInflammationObesity	2003	5.8K
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance Haiyan Xu, Glenn T. Barnes, Qing Yang, Journal of Clinical Investigation Metabolic DisorderImmunologyInsulin SignalingInflammationObesity	2003	5.6K
Identification and expression cloning of a leptin receptor, OB-R Louis A. Tartaglia, Marlene Dembski, Xun Weng, Cell Signal TransductionMolecular PhysiologyHypothalamic PeptideLeptin ReceptorNeuropeptide Receptor	1995	3.5K
Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice Dennis Huszar, Catherine Lynch, Victoria Fairchild-Huntress, Cell ObesityMetabolic SyndromeEnergy HomeostasisSignal TransductionAppetite Control	1997	3K
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands, New England Journal of Medicine	2013	2.8K
IKKε and TBK1 are essential components of the IRF3 signaling pathway Katherine A. Fitzgerald, Sarah M. McWhirter, L. Kerrie, Nature Immunology Signal TransductionSignaling PathwayCell RegulationMolecular RegulationGene Expression	2003	2.7K
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease William J. Sandborn, Brian G. Feagan, Paul Rutgeerts, New England Journal of Medicine	2013	2.6K
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma Paul G. Richardson, Bart Barlogie, James R. Berenson, New England Journal of Medicine	2003	2.6K
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein Dora Games, David S. Adams, Ree Alessandrini, Nature Alzheimer-type NeuropathologyNeurodegenerative DiseasesAlzheimer's DiseaseMolecular NeuroscienceTransgenic Mouse Models	1995	2.5K
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, New England Journal of Medicine	2005	2.5K

Page 1